EP2157967
Sviflausnarsamsetningar af insúlínörvandi peptíðum og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.4.2008EP published:
16.1.2013EP application number:
08743213.4
EP translation filed:
27.3.2013Grant published:
15.4.2013EPO information:
European Patent Register
Max expiry date:
21.4.2028Expiry date:
21.4.2026Next due date:
30.4.2026
Title:
SUSPENSION FORMULATIONS OF INSULINOTROPIC PEPTIDES AND USES THEREOF
Timeline
Owner
Name:
i2O Therapeutics, Inc.Address:
700 Main Street, Cambridge, MA 02139, US
Inventor
Name:
ALESSI, Thomas, R.Address:
Hayward, CA, US
Name:
MERCER, Ryan, D.Address:
Dublin, CA, US
Name:
ROHLOFF, Catherine, M.Address:
Los Altos, CA, US
Name:
YANG, BingAddress:
Redwood City, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
926005 PDate:
23.4.2007Country:
US
Number:
72202 PDate:
28.3.2008Country:
US
Classification
Categories:
A61K 9/10, A61K 9/16, A61K 47/14, A61K 9/00, A61K 9/70, A61K 38/26, C07K 7/06, C07K 14/605
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 4.4.2013
Expires: 21.4.2014
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 1.4.2014
Expires: 21.4.2015
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 31.3.2015
Expires: 21.4.2016
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 31.3.2016
Expires: 21.4.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 31.3.2017
Expires: 21.4.2018
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 3.4.2018
Expires: 21.4.2019
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 2.4.2019
Expires: 21.4.2020
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 31.3.2020
Expires: 21.4.2021
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 20.4.2021
Expires: 21.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 31.3.2022
Expires: 21.4.2023
Payer: Patice ehf.
Number: 16
Paid: 31.3.2023
Expires: 21.4.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 2.4.2024
Expires: 21.4.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.4.2025
Expires: 21.4.2026
Payer: Árnason Faktor ehf.